Net Clin. 361 366 727 (7.1) 391 0.320 0.95 0.94 0.337 Outcome (7.1) (7.2) (7.6) (0.83, (0.83, 1.10) 1.06) ASA (N) 349 348 697 353 CV 27 24 51 (7.3) 36 0.234 0.64 0.69 0.084 Dth/MI/St (7.7) (6.9) (0.38, (0.45, 1.07) 1.05) Dth/MI/St 28 24 52 (7.5) 36 0.291 0.64 0.70 0.101 (8.0) (6.9) (0.38, (0.46, 1.07) 1.07)
Net Clin. Outcome 361 (7.1) 366 (7.2) 727 (7.1) 391 (7.6) 0.320 0.95 (0.83, 1.10) 0.94 (0.83, 1.06) 0.337 ASA (N) 349 348 697 353 CV Dth/MI/St 27 (7.7) 24 (6.9) 51 (7.3) 36 0.234 0.64 (0.38, 1.07) 0.69 (0.45, 1.05) 0.084 Dth/MI/St 28 (8.0) 24 (6.9) 52 (7.5) 36 0.291 0.64 (0.38, 1.07) 0.70 (0.46, 1.07) 0.101
auspar-rivaroxaban-131111.docx